Top ▲
Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).
« Hide More detailed introduction
Trace amine-associated receptors were discovered from a search for novel 5-HT receptors [1], where 15 mammalian orthologues were identified and divided into two families. The TA1 receptor (nomenclature as agreed by the NC-IUPHAR Subcommittee for the Trace amine receptor [4]) has affinity for the endogenous trace amines tyramine, β-phenylethylamine and octopamine in addition to the classical amine dopamine [1]. Emerging evidence suggests that TA1 is a modulator of monoaminergic activity in the brain [8] with TA1 and dopamine D2 receptors shown to form constitutive heterodimers when co-expressed [3]. In addition to trace amines, receptors can be activated by amphetamine-like psychostimulants, and endogenous thyronamines.
TA1 receptor C Show summary » More detailed page |
Database page citation (select format):
Concise Guide to PHARMACOLOGY citation:
Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA et al. (2023) The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors. Br J Pharmacol. 180 Suppl 2:S23-S144.
In addition to TA1, in man there are up to 5 functional TAAR genes (TAAR2,5,6,8,9). See [1] for detailed discussion. The product of the gene TAAR2 (also known as GPR58) appears to respond to β-phenylethylamine > tyramine and to couple through Gs [1].
TAAR3, in some individuals, and TAAR4 are pseudogenes in man, although functional in rodents. The signalling characteristics and pharmacology of TAAR5 (PNR, Putative Neurotransmitter Receptor: TAAR5, O14804), TAAR6 (Trace amine receptor 4, TaR-4: TAAR6, 96RI8), TAAR8 (Trace amine receptor 5, GPR102: TAAR8, Q969N4 ) and TAAR9 (trace amine associated receptor 9: TAAR9, 96RI9) are lacking. The thyronamines, endogenous derivatives of thyroid hormone, have affinity for rodent cloned trace amine receptors, including TA1 [6]. An antagonist EPPTB has recently been described with a pKi of 9.1 at the mouse TA1 but >5.3 for human TA1 [7].